ISABL Trademark

Trademark Overview


On Wednesday, March 16, 2022, a trademark application was filed for ISABL with the United States Patent and Trademark Office. The USPTO has given the ISABL trademark a serial number of 97315383. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, August 15, 2024. This trademark is owned by Isabl Inc.. The ISABL trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment

Providing genome and transcriptome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development; platform as a service (PaaS) featuring software for use accessing, reviewing, analyzing, and interpreting genome and transcriptome sequencing data
isabl

General Information


Serial Number97315383
Word MarkISABL
Filing DateWednesday, March 16, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, August 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements


Goods and ServicesAnalysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment
Goods and ServicesProviding genome and transcriptome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development; platform as a service (PaaS) featuring software for use accessing, reviewing, analyzing, and interpreting genome and transcriptome sequencing data

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIsabl Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10007

Party NameIsabl Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007

Trademark Events


Event DateEvent Description
Wednesday, December 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 19, 2022NEW APPLICATION ENTERED
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 27, 2022ASSIGNED TO EXAMINER
Tuesday, January 10, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, February 17, 2023NON-FINAL ACTION WRITTEN
Monday, February 13, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, February 17, 2023NON-FINAL ACTION E-MAILED
Friday, February 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, May 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 14, 2024SOU EXTENSION 1 GRANTED
Wednesday, February 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 14, 2024SOU EXTENSION 1 FILED
Wednesday, June 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 15, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2024SOU EXTENSION 2 FILED
Thursday, August 15, 2024SOU EXTENSION 2 GRANTED
Thursday, February 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED